Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

Li, Jia-Yi, Englund, Elisabet, Holton, Janice L, Soulet, Denis, Hagell, Peter, Lees, Andrew J, Lashley, Tammaryn, Quinn, Niall P +6 more·2008·Nature Medicine

DOI 10.1038/nm1746

Cited by (1,002)

Items 801–900 of 1,002

Inflammation in Parkinson's disease: Cause or consequence?
Stanley H. Appel · 2012 · Movement Disorders
Prion Properties of SOD1 in Amyotrophic Lateral Sclerosis and Potential Therapy
Caroline Sibilla, Anne Bertolotti · 2017 · Cold Spring Harbor Perspectives in Biology
α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies
Alessandra Bigi, Roberta Cascella, Cristina Cecchi · 2023 · Neural Regeneration Research
α‐Synuclein in Parkinson's Disease: From Bench to Bedside
Gabriele Bellini, Vanessa D’Antongiovanni, Giovanni Palermo, Luca Antonioli, Matteo Fornai, Roberto Ceravolo, Nunzia Bernardini, Pascal Derkinderen, Carolina Pellegrini · 2024 · Medicinal Research Reviews
Pathogenesis of Parkinson’s Disease
Bin Xiao, Zhidong Zhou, Yinxia Chao, Eng-King Tan · 2025 · Neurologic Clinics
Nerve cells immunoreactive for p62 in select hypothalamic and brainstem nuclei of controls and Parkinson’s disease cases
Heiko Braak, Dietmar Rudolf Thal, Kelly Del Tredici · 2010 · Journal of Neural Transmission
Altered Serum IgG Levels to α-Synuclein in Dementia with Lewy Bodies and Alzheimer’s Disease
Niklas K. U. Koehler, Elke Stransky, Mona Shing, Susanne Gaertner, Mirjam Meyer, Brigitte Schreitmüller, Thomas Leyhe, Christoph Laske, Walter Maetzler, Phillipp Kahle et al. · 2013 · PLoS ONE
New Frontiers in Parkinson's Disease: From Genetics to the Clinic
Lamya S. Shihabuddin, Patrik Brundin, J. Timothy Greenamyre, Diane T. Stephenson, S. Pablo Sardi · 2018 · Journal of Neuroscience
The contribution of Parkin, PINK1 and DJ‐1 genes to selective neuronal degeneration in Parkinson's disease
Marc van der Vlag, Robbert Havekes, Pim R.A. Heckman · 2020 · European Journal of Neuroscience
Anti-aggregation Effects of Phenolic Compounds on α-synuclein
Kenjiro Ono, Mayumi Tsuji, Tritia R. Yamasaki, Giulio Maria Pasinetti · 2020 · Molecules
TLR7/8 in the Pathogenesis of Parkinson’s Disease
Michela Campolo, Alessia Filippone, Carmelo Biondo, Giuseppe Mancuso, Giovanna Casili, Marika Lanza, Salvatore Cuzzocrea, Emanuela Esposito, Irene Paterniti · 2020 · International Journal of Molecular Sciences
Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
Sheila K. Pirooznia, Liana S. Rosenthal, Valina Lynn Dawson, Ted M. Dawson · 2021 · Pharmacological Reviews
The expanding realm of prion phenomena in neurodegenerative disease
Bess E Frost, Marc I. Diamond · 2009 · Prion
Do alpha-synuclein vector injections provide a better model of Parkinson's disease than the classic 6-hydroxydopamine model?
Hanna S. Lindgren, Mariah J. Lelos, Stephen B. Dunnett · 2012 · Experimental Neurology
Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration
Wen Li, Jiayi Li · 2024 · Translational Neurodegeneration
International Parkinson and Movement Disorder Society Viewpoint on Biological Frameworks of Parkinson's Disease: Current Status and Future Directions
Lorraine V. Kalia, Daniela Berg, Jeffrey H. Kordower, Kathleen M. Shannon, John‐Paul Taylor, Francisco Cardoso, Jennifer G. Goldman, Beomseok Jeon, Wassilios G. Meissner, Marina A.J. Tijssen et al. · 2024 · Movement Disorders
Promising Targets for the Treatment of Neurodegenerative Diseases
Samantha Budd Haeberlein, TJR Harris · 2015 · Clinical Pharmacology & Therapeutics
Convergent Replication of Mouse Synthetic Prion Strains
Sina Ghaemmaghami, David W. Colby, Hoang-Oanh B. Nguyen, Shigenari Hayashi, Abby Oehler, Stephen J. DeArmond, Stanley B. Prusiner · 2013 · American Journal Of Pathology
Non-human primate models of PD to test novel therapies
Marc Morissette, Thérèse Di Paolo · 2017 · Journal of Neural Transmission
A Critical LRRK at the Synapse? The Neurobiological Function and Pathophysiological Dysfunction of LRRK2
Naila Kuhlmann, Austen J. Milnerwood · 2020 · Frontiers in Molecular Neuroscience
Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders
Aurélie de Rus Jacquet, Hélèna L. Denis, Francesca Cicchetti, Melanie Alpaugh · 2021 · Molecular Psychiatry
Nonclinical safety evaluation, pharmacokinetics, and target engagement of Lu AF82422, a monoclonal IgG1 antibody against alpha-synuclein in development for treatment of synucleinopathies
Lone Fjord‐Larsen, Annemette Thougaard, Karen Malene Wegener, Joan Christiansen, Frank Larsen, Lise Maj Schrøder-Hansen, Marianne Kaarde, Dorte Kornerup Ditlevsen · 2021 · mAbs
The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's disease
Michael X. Henderson, Martin T. Henrich, Fanni F. Geibl, Wolfgang H. Oertel, Patrik Brundin, Dalton James Surmeier · 2022 · Neurobiology of Disease
Impact of sex on neuroimmune contributions to Parkinson’s disease
Mélanie Bourque, Marc Morissette, Denis Soulet, Thérèse Di Paolo · 2023 · Brain Research Bulletin
Past, present, and future of cell replacement therapy for parkinson’s disease: a novel emphasis on host immune responses
Tae-Yoon Park, Jeha Jeon, Young Cha, Kwang‐Soo Kim · 2024 · Cell Research
“Prion-like” seeding and propagation of oligomeric protein assemblies in neurodegenerative disorders
Silvia Zampar, Sonja E. Di Gregorio, Gustavo Grimmer, Joel C. Watts, Martin Ingelsson · 2024 · Frontiers in Neuroscience
Multiple system atrophy
Gregor Karl Wenning, Florian Krismer · 2013 · Handbook of clinical neurology
Studies of lipopolysaccharide effects on the induction of α-synuclein pathology by exogenous fibrils in transgenic mice
Nicola J. Rutherford, Amanda N. Sacino, Mieu Brooks, Carolina Ceballos‐Diaz, Thomas B. Ladd, Jasie K. Howard, Todd Eliot Golde, Benoit I. Giasson · 2015 · Molecular Neurodegeneration
A refined concept: α-synuclein dysregulation disease
Hideki Mochizuki, Chi‐Jing Choong, Eliezer Masliah · 2018 · Neurochemistry International
Microglial inclusions and neurofilament light chain release follow neuronal α-synuclein lesions in long-term brain slice cultures
Melanie Barth, Mehtap Bacioglu, Niklas Schwarz, Renata Novotny, Janine Brandes, Marc Welzer, Sonia Mazzitelli, Lisa M. Häsler, Manuel Schweighauser, Thomas V. Wuttke et al. · 2021 · Molecular Neurodegeneration
Role of post-translational modifications on the alpha-synuclein aggregation-related pathogenesis of Parkinson’s disease
Hajung Yoo, Jeongmin Lee, Bokwang Kim, Heechang Moon, Huisu Jeong, Kyungmi Lee, Woojeung Song, Junho K. Hur, Yohan Oh · 2022 · BMB Reports
Olfactory heterogeneity in LRRK2 related Parkinsonism
Laura Silveira‐Moriyama, Renato Puppy Munhoz, Margarete de Jesus Carvalho, Salmo Raskin, Ekaterina A. Rogaeva, Patrícia de Carvalho Aguiar, Rodrigo A. Bressan, Andre Carvalho Felicio, Orlando Graziani Póvoas Barsottini, Luiz Augusto Franco de Andrade et al. · 2010 · Movement Disorders
From Prion Diseases to Prion-Like Propagation Mechanisms of Neurodegenerative Diseases
Isabelle Acquatella-Tran Van Ba, Thibaut Imberdis, Véronique Perrier · 2013 · International Journal of Cell Biology
The yin and yang of α-synuclein-associated epigenetics in Parkinson’s disease
Maria Angeliki S. Pavlou, Raquel Pinho, Isabel Paiva, Tiago F. Outeiro · 2016 · Brain
Prion-like propagation of α-synuclein in neurodegenerative diseases
Airi Tarutani, Masato Hasegawa · 2019 · Progress in molecular biology and translational science
Progress in the genetic analysis of Parkinson’s disease
Andrew Singleton, John Hardy · 2019 · Human Molecular Genetics
Systemic α-synuclein injection triggers selective neuronal pathology as seen in patients with Parkinson’s disease
Wei‐Li Kuan, Katherine M. Stott, Xiaoling He, Tobias Wood, Sujeong Yang, Jessica C. F. Kwok, Katie Hall, Yanyan Zhao, Ole Tietz, Franklin I. Aigbirhio et al. · 2019 · Molecular Psychiatry
Prodromal PD: A new nosological entity
Eva Schaeffer, Ronald B. Postuma, Daniela Berg · 2020 · Progress in brain research
Parkinson Data Analysis and Prediction System Using Multi-Variant Stacked Auto Encoder
Gayathri Nagasubramanian, S. Muthuramalingam, Fadi M. Al-Turjman, Georgios Tsaramirsis · 2020 · IEEE Access
Lewy Body Disease Primate Model with α‐Synuclein Propagation from the Olfactory Bulb
Masanori Sawamura, Hirotaka Onoe, Hideo Tsukada, Kaoru Isa, Hodaka Yamakado, Shinya Okuda, Masashi Ikuno, Yusuke Hatanaka, Shigeo Murayama, Norihito Uemura et al. · 2022 · Movement Disorders
Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies
Shady Rahayel, Christina Tremblay, Andrew Vo, Bratislav Mišić, Stéphane Lehéricy, Isabelle Arnulf, Marie Vidailhet, Jean-Christophe Corvol, the ICEBERG Study Group, Marie Vidailhet et al. · 2023 · Brain
α-Synuclein and DJ-1 as Potential Biological Fluid Biomarkers for Parkinson’s Disease
Masaaki Waragai, Kazunari Sekiyama, Akio Sekigawa, Yoshiki Takamatsu, Masayo Fujita, Makoto Hashimoto · 2010 · International Journal of Molecular Sciences
Rasagiline, a Suicide Inhibitor of Monoamine Oxidases, Binds Reversibly to α-Synuclein
Joe Kakish, Omid Tavassoly, Jeremy S. Lee · 2014 · ACS Chemical Neuroscience
The Appendix in Parkinson’s Disease: From Vestigial Remnant to Vital Organ?
Bryan A. Killinger, Viviane Labrie · 2019 · Journal of Parkinson s Disease
Differential seeding and propagating efficiency of α-synuclein strains generated in different conditions
Liu, Di, Guo, Jian-Jun, Su, Ji-Hui, Svanbergsson, Alexander, Yuan, Lin, Haikal, Caroline, Li, Wen, Gouras, Gunnar, Li, Jia-Yi · 2021 · Translational Neurodegeneration
Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy
Lai, Thuy Thi, Kim, Yun Joong, Ma, Hyeo-il, Kim, Young Eun · 2022 · Journal of Movement Disorders
Enriched Environmental Conditions Modify the Gut Microbiome Composition and Fecal Markers of Inflammation in Parkinson’s Disease
Yogesh Singh, Mohamed S. El-Hadidi, Jakob Admard, Zinah Wassouf, Julia Maria Schulze-Hentrich, Ursula Kohlhofer, Leticia Quintanilla‐Martínez, Daniel H. Huson, Olaf Rieß, Nicolas Casadei · 2019 · Frontiers in Neuroscience
LRRK2-Related Parkinson’s Disease Due to Altered Endolysosomal Biology With Variable Lewy Body Pathology: A Hypothesis
Pilar Rivero-Ríos, María Romo-Lozano, Rachel Fasiczka, Yahaira Naaldijk, Sabine Hilfiker · 2020 · Frontiers in Neuroscience
Epigenetic inactivation of the autophagy–lysosomal system in appendix in Parkinson’s disease
Juozas Gordevičius, Peipei Li, Lee L. Marshall, Bryan A. Killinger, Sean Lang, Elizabeth Ensink, Nathan C. Kuhn, Wei Cui, Nazia Maroof, Roberta Lauria et al. · 2021 · Nature Communications
Brain-gut-microbiota axis in Parkinson’s disease: A historical review and future perspective
Siyu Dong, Mei Sun, Chuan Hua He, Hong Cheng · 2022 · Brain Research Bulletin
COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences
Narjes Baazaoui, Khalid Iqbal · 2022 · Journal of Alzheimer s Disease
Truncation or proteolysis of α-synuclein in Parkinsonism
Sharad Kumar Suthar, Sang‐Yoon Lee · 2023 · Ageing Research Reviews
α‐Synuclein induced cell death in mouse hippocampal (HT22) cells is mediated by nitric oxide‐dependent activation of caspase‐3
Agata Adamczyk, Anna Wilkaniec, Grzegorz Arkadiusz Czapski, Joanna Benigna Strosznajder · 2010 · FEBS Letters
Proaggregant nuclear factor(s) trigger rapid formation of α-synuclein aggregates in apoptotic neurons
Peizhou Jiang, Ming Gan, Shu-Hui C. Yen, Simon Moussaud, Pamela J. McLean, Dennis W. Dickson · 2016 · Acta Neuropathologica
Gut Microbiome-Modified Polyphenolic Compounds Inhibit α-Synuclein Seeding and Spreading in α-Synucleinopathies
Tritia R. Yamasaki, Kenjiro Ono, Lap Ho, Giulio Maria Pasinetti · 2020 · Frontiers in Neuroscience
Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease
Natalia Cecilia Prymaczok, Pablo Nicolás De Francesco, Samanta Mazzetti, Marie Humbert‐Claude, Liliane Tenenbaum, Graziella Cappelletti, Eliezer Masliah, Mario Perelló, Roland Riek, Juan Gerez · 2024 · npj Parkinson s Disease
Insights into Mechanisms of Chronic Neurodegeneration
Abigail B. Diack, James D. Alibhai, Rona M. Barron, Barry Matthew Bradford, Pedro Piccardo, Jean C. Manson · 2016 · International Journal of Molecular Sciences
The underlying mechanism of prodromal PD: insights from the parasympathetic nervous system and the olfactory system
Shuying Liu, Piu Chan, A. Jon Stoessl · 2017 · Translational Neurodegeneration
Tissue Engineering and Biomaterial Strategies to Elicit Endogenous Neuronal Replacement in the Brain
Erin M Purvis, John C. O'Donnell, H. Chen, D. K. Cullen · 2020 · Frontiers in Neurology
Pathophysiology of Parkinson's disease: Mitochondria, alpha-synuclein and much more…
Tiphaine Rouaud, Anne-Gaëlle Corbillé, Laurène Leclair‐Visonneau, Adrien de Guilhem de Lataillade, Arthur Lionnet, Cécile Preterre, Philippe Damier, Pascal Derkinderen · 2020 · Revue Neurologique
Using multi-organ culture systems to study Parkinson’s disease
Orly Reiner, Tamar Sapir, Arpan Parichha · 2020 · Molecular Psychiatry
The Role of Glial Mitochondria in α-Synuclein Toxicity
Yu‐Mi Jeon, Younghwi Kwon, Myungjin Jo, Shinrye Lee, Seyeon Kim, Hyung‐Jun Kim · 2020 · Frontiers in Cell and Developmental Biology
Specificity of Adaptive Immune Responses in Central Nervous System Health, Aging and Diseases
Chiara Rickenbach, Christoph Gericke · 2022 · Frontiers in Neuroscience
The neurogenic niche in the carotid body and its applicability to antiparkinsonian cell therapy
José López‐Barneo, Ricardo Pardal, Patricia Ortega‐Sáenz, Rocío Durán, Javier Villadiego, Juan José Toledo‐Aral · 2009 · Journal of Neural Transmission
Extracellular alpha‐synuclein induces calpain‐dependent overactivation of cyclin‐dependent kinase 5 in vitro
Grzegorz Arkadiusz Czapski, Magdalena Gąssowska-Dobrowolska, Anna Wilkaniec, Magdalena Cieślik, Agata Adamczyk · 2013 · FEBS Letters
Parkinson's disease as a member of Prion-like disorders
María Eugenia Herva, Maria Grazia Spillantini · 2014 · Virus Research
Reciprocal signals between microglia and neurons regulate α-synuclein secretion by exophagy through a neuronal cJUN-N-terminal kinase-signaling axis
Dan Ploug Christensen, Patrick Ejlerskov, Izabela Rasmussen, Frederik Vilhardt · 2016 · Journal of Neuroinflammation
Exogenous α-synuclein hinders synaptic communication in cultured cortical primary rat neurons
Gerco C. Hassink, C.C. Raiss, Ine M. J. Segers‐Nolten, Richard J. A. Van Wezel, Vinod Subramaniam, Joost le Feber, Mireille M. A. E. Claessens · 2018 · PLoS ONE
Shifts and drifts in prion science
Adriano Aguzzi, Elena De Cecco · 2020 · Science
Modeling sleep alterations in Parkinson's disease: how close are we to valid translational animal models?
Fifel, Karim, Piggins, Hugh, Deboer, Tom · 2016 · Sleep Medicine Reviews
Propagation of the Prion Phenomenon: Beyond the Seeding Principle
Christian Münch, Anne Bertolotti · 2012 · Journal of Molecular Biology
Cell replacement therapy for Parkinson’s disease: how close are we to the clinic?
J. Ganz, N. Lev, E. Melamed, D. Offen · 2011 · Expert Review of Neurotherapeutics
Human Pluripotent Stem Cell Therapy for Huntington's Disease: Technical, Immunological, and Safety Challenges
Camille Nicoleau, Pedro Viegas, Marc Peschanski, Anselme L. Perrier · 2011 · Neurotherapeutics
Interaction of LRRK2 and α-Synuclein in Parkinson’s Disease
João Paulo Lima Daher · 2017 · Advances in neurobiology
Live calcium and mitochondrial imaging in the enteric nervous system of Parkinson patients and controls
An-Sofie Desmet, Carla Cirillo, Jan F. Tack, Wim Vandenberghe, Pieter Vanden Berghe · 2017 · eLife
Stereotaxic Targeting of Alpha-Synuclein Pathology in Mouse Brain Using Preformed Fibrils
Bin Zhang, Victoria M. Kehm, Ronald J. Gathagan, Susan N. Leight, John Q. Trojanowski, Virginia M.‐Y. Lee, Kelvin C. Luk · 2019 · Methods in molecular biology
Antibody-based therapies for Huntington’s disease: current status and future directions
Hélèna L. Denis, Linda Suzanne David, Francesca Cicchetti · 2019 · Neurobiology of Disease
Mechanistic insights into the protective roles of polyphosphate against amyloid cytotoxicity
Justine Lempart, Eric Tse, James A. Lauer, Magdalena I. Ivanova, Alexandra Sutter, Nicholas G. Yoo, Philipp Huettemann, Daniel R. Southworth, Ursula Jakob · 2019 · Life Science Alliance
Cynomolgus Monkeys With Spontaneous Type-2-Diabetes-Mellitus-Like Pathology Develop Alpha-Synuclein Alterations Reminiscent of Prodromal Parkinson’s Disease and Related Diseases
Yan Sun, Chuang Guo, Lin Yuan, Wen Li, Zhan‐You Wang, Feng Yue, Jiayi Li · 2020 · Frontiers in Neuroscience
The role of glia in Parkinson's disease: Emerging concepts and therapeutic applications
Katarzyna Z. Kuter, Maria Angela Cenci, Anna Rosa Carta · 2020 · Progress in brain research
On the Right Track to Treat Movement Disorders: Promising Therapeutic Approaches for Parkinson’s and Huntington’s Disease
Paulina Troncoso-Escudero, Denisse Sepúlveda, Rodrigo Pérez-Arancibia, Alejandra V. Parra, J. Arcos, Felipe Grunenwald, René L. Vidal · 2020 · Frontiers in Aging Neuroscience
The Nigral Coup in Parkinson’s Disease by α-Synuclein and Its Associated Rebels
Jeswinder Sian‐Hülsmann, Peter Franz Riederer · 2021 · Cells
Persistent dyskinesias in patients with fetal tissue transplantation for Parkinson disease
Paul E. Greene, Stanley Fahn, David Eidelberg, Kimberly B. Bjugstad, Robert E. Breeze, Curt R. Freed · 2021 · npj Parkinson s Disease
Cell-therapy for Parkinson’s disease: a systematic review and meta-analysis
Fang Wang, Zhengwu Sun, Daoyong Peng, Shikha Gianchandani, Weidong Le, Johannes Boltze, Shen Li · 2023 · Journal of Translational Medicine
Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates
Julia Chocarro, Alberto J. Rico, Goiaz Ariznabarreta, Elvira Roda, Adriana Honrubia, María Collantes, Iván Peñuelas, Alfonso Vázquez, Ana Isabel Rodriguez-Perez, José Luis Labandeira-García et al. · 2023 · Brain
Is Parkinson’s Disease Truly a Prion-Like Disorder? An Appraisal of Current Evidence
Aneesha Chauhan, Alexander F. Jeans · 2015 · Neurology Research International
Will Stem Cell Biology Generate New Therapies for Parkinson's Disease?
Ron D. G. McKay, Raja Kittappa · 2008 · Neuron
Immunotherapy Targeting Neurodegenerative Proteinopathies: α-Synucleinopathies and Tauopathies
Jung Hwan Shin, Han‐Joon Kim, Beomseok Jeon · 2019 · Journal of Movement Disorders
α-Synuclein filaments from transgenic mouse and human synucleinopathy-containing brains are major seed-competent species
Sophie Morgan, Isabelle Lavenir, Juan Fan, Masami Masuda‐Suzukake, Daniela Passarella, Michael A. Deture, Dennis W. Dickson, Bernardino Francesco Ghetti, Michel Goedert · 2020 · Journal of Biological Chemistry
Neuropathology of Lewy body dementia: Lewy-related pathology, α-synuclein oligomers, and comorbid pathologies
Hiroaki Sekiya, Tomoyasu Matsubara, Michael A. Deture, Dennis W. Dickson · 2025 · Molecular Neurodegeneration
Toxic Protein Spread in Neurodegeneration: Reality versus Fantasy
Eleanna Kara, Jordan D. Marks, Adriano Aguzzi · 2018 · Trends in Molecular Medicine
From Synaptic Protein to Prion: The Long and Controversial Journey of α-Synuclein
Antonio Heras‐Garvin, Nadia Stefanova · 2020 · Frontiers in Synaptic Neuroscience
Preserving cognitive function in patients with Alzheimer's disease: The Alzheimer's disease neuroprotection research initiative (ADNRI)
Jie Liu, Heleen M.M. van Beusekom, Xian‐Le Bu, Gong Chen, Paulo Henrique Rosado-de-Castro, Xiaochun Chen, Xiaowei Chen, Andrew N. Clarkson, Tracy D. Farr, YuHong Fu et al. · 2023 · Neuroprotection/Neuroprotection (Chichester, England. Print)
Biochemical and strain properties of CJD prions: complexity versus simplicity
Stéphane Haı̈k, Jean‐Philippe Brandel · 2011 · Journal of Neurochemistry
Drug discovery in Parkinson's disease: update and developments in the use of cellular models
Steven M. Finkbeiner, Skibinski · 2011 · International Journal of High Throughput Screening
Generation of Dopamine Neurons with Improved Cell Survival and Phenotype Maintenance Using a Degradation-Resistant Nurr1 Mutant
A-Young Jo, Mi-Young Kim, Hyun‐Seob Lee, Yong‐Hee Rhee, Jeong Eun Lee, Kwang‐Hyun Baek, Chang‐Hwan Park, Hyun-Chul Koh, Incheol Shin, Yong‐Sung Lee et al. · 2009 · Stem Cells
The immunological challenges of cell transplantation for the treatment of Parkinson's disease
Amanda L. Piquet, Kala Venkiteswaran, Neena I. Marupudi, Matthew Berk, Thyagarajan Subramanian · 2012 · Brain Research Bulletin
Aggregation Modulators Interfere with Membrane Interactions of β2-Microglobulin Fibrils
Tania Sheynis, Anat Friediger, Wei‐Feng Xue, Andrew L. Hellewell, Kevin W. Tipping, Eric W. Hewitt, Sheena E. Radford, Raz Jelinek · 2013 · Biophysical Journal
Pathology: The prion principle
Simon J. Makin · 2016 · Nature
Stimulation of synaptoneurosome glutamate release by monomeric and fibrillated α‐synuclein
Theodore A. Sarafian, Kaitlyn Littlejohn, Sarah Y. Yuan, Charlene Fernandez, Marianne C. Cilluffo, Bon‐Kyung Koo, Julian P. Whitelegge, Joseph B. Watson · 2017 · Journal of Neuroscience Research